Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H9N4O2S.Ag |
Molecular Weight | 357.137 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C2=NC=CC=N2
InChI
InChIKey=UEJSSZHHYBHCEL-UHFFFAOYSA-N
InChI=1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
Molecular Formula | C10H10N4O2S |
Molecular Weight | 250.277 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Ag |
Molecular Weight | 107.8682 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:30 GMT 2023
by
admin
on
Fri Dec 15 15:35:30 GMT 2023
|
Record UNII |
W46JY43EJR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
S01AX02
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
WHO-ATC |
D06BA01
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
NDF-RT |
N0000175503
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
WHO-VATC |
QD06BA01
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
FDA ORPHAN DRUG |
110798
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
WHO-ATC |
D06BA51
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
CFR |
21 CFR 524.802
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
CFR |
21 CFR 310.548
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.2
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
NDF-RT |
N0000008048
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
WHO-VATC |
QD06BA51
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
W46JY43EJR
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
SILVER SULFADIAZINE
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | Description: A white or almost white, crystalline powder. Solubility: Sulfadiazine silver is practically insoluble in water and ethanol (~750 g/l) TS; slightly soluble in acetone R and ether R; soluble in ammonia (~260 g/l) TS. Category: Anti-infective drug. Storage: Sulfadiazine silver should be kept in a well-closed container, protected from light. Requirement: Sulfadiazine silver contains not less than 98.0% and not more than 102.0% of C10H9AgN4O2S, calculated with reference to the dried substance. | ||
|
1612608
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
W46JY43EJR
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
m10305
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
4142
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
244-834-5
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
SUB04622MIG
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
DTXSID4048646
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
D012837
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL439
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
9142
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
DB05245
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
SILVER SULFADIAZINE
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
22199-08-2
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
441244
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
9793
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | RxNorm | ||
|
1152234-18-8
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
ALTERNATIVE | |||
|
100000088916
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY | |||
|
C66567
Created by
admin on Fri Dec 15 15:35:30 GMT 2023 , Edited by admin on Fri Dec 15 15:35:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY | |||
|
ACTIVE MOIETY |